Research

Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Going into science: Women scientists at Boston Children's offer advice to girls

We gathered women scientists from across Boston Children’s Hospital and asked them to advise girls wanting to enter the field. Hear what they had to say, and go in depth here for more wise words and a taste of what they’re investigating.

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 10/27/2020 6:48:45 PM
RT @jnutritionorg: Dr. David S. Ludwig from @BostonChildrens and @harvardmed considers the ketogenic diet and its growing popularity in one…
BCH Innovation News @BCH_Innovation 10/27/2020 2:00:02 PM
With chronic #pain in children being frequently undertreated, @cbsieberg_PhD speaks to the @nytimes about her effor… https://t.co/AfcdKUJpXM
BCH Innovation News @BCH_Innovation 10/26/2020 6:35:47 PM
RT @DFBC_PedCare: “If you look at all types of cancer survivors as a group, certainly endocrinopathies are among the most common late effec…
BCH Innovation News @BCH_Innovation 10/26/2020 3:00:01 PM
A @JAMAPediatrics study of hospitalized children whose families have limited comfort with English found they were n… https://t.co/sbb87f8C0y
BCH Innovation News @BCH_Innovation 10/25/2020 7:00:01 PM
Another “fish to bedside” drug? A calmodulin inhibitor was found, in a zebrafish model of Diamond-Blackfan anemia,… https://t.co/VtZG3CQcKl
BCH Innovation News @BCH_Innovation 10/25/2020 5:00:00 PM
Congratulations to @joelhirschhorn and Judy Lieberman, MD, PhD, who were elected into the @theNAMedicine. Read more… https://t.co/pH9x4HNSPj
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer